NO20050127L - 9-alpha-substituted ostratrienes as selectively active oestrogens - Google Patents
9-alpha-substituted ostratrienes as selectively active oestrogensInfo
- Publication number
- NO20050127L NO20050127L NO20050127A NO20050127A NO20050127L NO 20050127 L NO20050127 L NO 20050127L NO 20050127 A NO20050127 A NO 20050127A NO 20050127 A NO20050127 A NO 20050127A NO 20050127 L NO20050127 L NO 20050127L
- Authority
- NO
- Norway
- Prior art keywords
- ostratrienes
- oestrogens
- alpha
- substituted
- selectively active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0055—Estrane derivatives not substituted in position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10226326A DE10226326A1 (en) | 2002-06-11 | 2002-06-11 | 9-alpha-substituted estratrienes as selective estrogens |
PCT/EP2003/006172 WO2003104253A2 (en) | 2002-06-11 | 2003-06-11 | 9-alpha-substituted estratrienes as selectively active estrogen |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20050127D0 NO20050127D0 (en) | 2005-01-10 |
NO20050127L true NO20050127L (en) | 2005-03-11 |
NO329563B1 NO329563B1 (en) | 2010-11-15 |
Family
ID=29723144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050127A NO329563B1 (en) | 2002-06-11 | 2005-01-10 | 9-alpha-substituted ostratrienes as selectively active oestrogens, pharmaceutical compositions containing the compounds, and their use in the preparation of pharmaceutical agents |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1517914B1 (en) |
JP (1) | JP4615998B2 (en) |
KR (1) | KR101006612B1 (en) |
CN (1) | CN1293090C (en) |
AR (1) | AR040188A1 (en) |
AT (1) | ATE303397T1 (en) |
AU (1) | AU2003242683B9 (en) |
BR (1) | BR0312140A (en) |
CA (1) | CA2486495C (en) |
CR (1) | CR10289A (en) |
CU (1) | CU23414B7 (en) |
DE (2) | DE10226326A1 (en) |
DK (1) | DK1517914T3 (en) |
EA (1) | EA008442B1 (en) |
EC (1) | ECSP055530A (en) |
ES (1) | ES2248770T3 (en) |
HK (1) | HK1081203A1 (en) |
HR (1) | HRP20050009B1 (en) |
IL (1) | IL165321A (en) |
MX (1) | MXPA04012491A (en) |
NO (1) | NO329563B1 (en) |
PE (1) | PE20040613A1 (en) |
PL (1) | PL209910B1 (en) |
RS (1) | RS50878B (en) |
TW (1) | TWI286140B (en) |
UA (1) | UA78062C2 (en) |
UY (1) | UY27844A1 (en) |
WO (1) | WO2003104253A2 (en) |
ZA (1) | ZA200500217B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027887A1 (en) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds |
PL1689410T3 (en) * | 2003-11-26 | 2008-10-31 | Bayer Schering Pharma Ag | Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol |
US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
DE102005057224A1 (en) * | 2005-11-29 | 2007-05-31 | Bayer Schering Pharma Ag | New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
JP2011511816A (en) * | 2008-02-13 | 2011-04-14 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | Drug delivery system with stabilizing effect |
EP2143432A1 (en) | 2008-07-11 | 2010-01-13 | Bayer Schering Pharma AG | 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer |
JP2012509286A (en) * | 2008-11-21 | 2012-04-19 | バイエル ファーマ アクチエンゲゼルシャフト | Drug delivery system |
JP2017529388A (en) | 2014-08-26 | 2017-10-05 | ベタニエン ホスピタル | Methods, agents and compositions for the treatment of inflammatory conditions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2336432A1 (en) * | 1973-07-13 | 1975-01-30 | Schering Ag | 3.17.18-TRIHYDROXY-1.3.5 (10) -OESTRATRIENE |
US6154158A (en) * | 1998-06-30 | 2000-11-28 | Qualcomm Incorporated | Digital-to-analog converter D.C. offset correction comparing converter input and output signals |
DE19906159A1 (en) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-hydroxyestratrienes as selectively active estrogens |
ES2286042T3 (en) * | 1999-11-02 | 2007-12-01 | Bayer Schering Pharma Aktiengesellschaft | 18-NOR-STEROIDS AS EFFECTIVE STROGENS SELECTIVELY. |
US7378404B2 (en) * | 2000-04-12 | 2008-05-27 | Schering Aktiengesellschaft | 8β-hydrocarbyl-substituted estratrienes for use as selective estrogens |
-
2002
- 2002-06-11 DE DE10226326A patent/DE10226326A1/en not_active Ceased
-
2003
- 2003-06-10 PE PE2003000575A patent/PE20040613A1/en not_active Application Discontinuation
- 2003-06-11 TW TW092115863A patent/TWI286140B/en not_active IP Right Cessation
- 2003-06-11 AU AU2003242683A patent/AU2003242683B9/en not_active Ceased
- 2003-06-11 ES ES03757065T patent/ES2248770T3/en not_active Expired - Lifetime
- 2003-06-11 EA EA200401544A patent/EA008442B1/en not_active IP Right Cessation
- 2003-06-11 DE DE50301116T patent/DE50301116D1/en not_active Expired - Lifetime
- 2003-06-11 AR ARP030102079A patent/AR040188A1/en active IP Right Grant
- 2003-06-11 AT AT03757065T patent/ATE303397T1/en active
- 2003-06-11 BR BR0312140-2A patent/BR0312140A/en not_active IP Right Cessation
- 2003-06-11 JP JP2004511321A patent/JP4615998B2/en not_active Expired - Fee Related
- 2003-06-11 KR KR1020047020133A patent/KR101006612B1/en not_active IP Right Cessation
- 2003-06-11 WO PCT/EP2003/006172 patent/WO2003104253A2/en active IP Right Grant
- 2003-06-11 CA CA2486495A patent/CA2486495C/en not_active Expired - Fee Related
- 2003-06-11 CN CNB038135027A patent/CN1293090C/en not_active Expired - Fee Related
- 2003-06-11 EP EP03757065A patent/EP1517914B1/en not_active Expired - Lifetime
- 2003-06-11 PL PL373090A patent/PL209910B1/en not_active IP Right Cessation
- 2003-06-11 DK DK03757065T patent/DK1517914T3/en active
- 2003-06-11 MX MXPA04012491A patent/MXPA04012491A/en active IP Right Grant
- 2003-06-11 RS YUP-1070/04A patent/RS50878B/en unknown
- 2003-06-11 UY UY27844A patent/UY27844A1/en not_active Application Discontinuation
- 2003-11-06 UA UAA200500212A patent/UA78062C2/en unknown
-
2004
- 2004-11-22 IL IL165321A patent/IL165321A/en not_active IP Right Cessation
- 2004-12-10 CU CU20040282A patent/CU23414B7/en not_active IP Right Cessation
-
2005
- 2005-01-05 HR HRP20050009AA patent/HRP20050009B1/en not_active IP Right Cessation
- 2005-01-10 EC EC2005005530A patent/ECSP055530A/en unknown
- 2005-01-10 NO NO20050127A patent/NO329563B1/en not_active IP Right Cessation
-
2006
- 2006-01-10 ZA ZA200500217A patent/ZA200500217B/en unknown
- 2006-01-27 HK HK06101276A patent/HK1081203A1/en not_active IP Right Cessation
-
2008
- 2008-09-16 CR CR10289A patent/CR10289A/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3473251T3 (en) | NICOTINE-CELLULOSE COMBINATION | |
DE60333919D1 (en) | SPIROINDOLINPIPERIDINDERIVATE | |
ATE457980T1 (en) | ARYLOXIMES | |
ATE534648T1 (en) | C-6-MODIFIED INDAZOLYLPYRROLOTRIAZINES | |
ATE318817T1 (en) | AZA-ARYLPIPERAZINE | |
ATE427876T1 (en) | HOVERBOAT | |
DE50212360D1 (en) | Anfahrhilfesteuerungsvorrichtung | |
DE50212349D1 (en) | HIRURGIE | |
DE50301200D1 (en) | WISCHBLATT | |
ATE349458T1 (en) | ETONOGESTRELESTER | |
NO20050127L (en) | 9-alpha-substituted ostratrienes as selectively active oestrogens | |
DK1556377T3 (en) | Cyclopropylthienylcarboxamides as fungicides | |
ATA1572002A (en) | MANAGEMENTSPLEISSKASSETTE | |
DE50301960D1 (en) | hydromount | |
DE50302660D1 (en) | Stopfmachine | |
DE50301464D1 (en) | threadlocking | |
ATA4142004A (en) | TRÄGERVERBAU | |
ATE469773T1 (en) | ZUGÖSE | |
DE50303317D1 (en) | SLOT-BREAKER | |
ATA19152002A (en) | HUBKUPPLUNG | |
ITMI20021327A1 (en) | NEW OSSIALCHILPIPERAZINE | |
ATE396192T1 (en) | N-SULFONYLAMINOTHIAZOLES | |
FR2840006B1 (en) | DEMONABLE CONSTRUCTION | |
DE50300322D1 (en) | ZYLINDERKOPFDICHTUNG | |
DE50303658D1 (en) | Postgutmessvorrichtung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE |
|
MM1K | Lapsed by not paying the annual fees |